Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
The US Food and Drug Administration (FDA) revised its compliance program guide (CPG) for preapproval inspections (PAIs) for new drugs. This update emphasizes a risk-based approach to making decisions ...
The VET90 blood gas analyzer is an in-clinic testing tool that delivers comprehensive results in just 35 seconds from a single 65 µL sample. With up to 18 key parameters, the VET90 is ideal for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results